152 related articles for article (PubMed ID: 18197601)
1. Mithramycin analogues generated by combinatorial biosynthesis show improved bioactivity.
Baig I; Perez M; Braña AF; Gomathinayagam R; Damodaran C; Salas JA; Méndez C; Rohr J
J Nat Prod; 2008 Feb; 71(2):199-207. PubMed ID: 18197601
[TBL] [Abstract][Full Text] [Related]
2. Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis.
Remsing LL; González AM; Nur-e-Alam M; Fernández-Lozano MJ; Braña AF; Rix U; Oliveira MA; Méndez C; Salas JA; Rohr J
J Am Chem Soc; 2003 May; 125(19):5745-53. PubMed ID: 12733914
[TBL] [Abstract][Full Text] [Related]
3. Expanding the Chemical Diversity of the Antitumoral Compound Mithramycin by Combinatorial Biosynthesis and Biocatalysis: The Quest for Mithralogs with Improved Therapeutic Window.
Méndez C; González-Sabín J; Morís F; Salas JA
Planta Med; 2015 Oct; 81(15):1326-38. PubMed ID: 26393942
[TBL] [Abstract][Full Text] [Related]
4. Identification of two genes from Streptomyces argillaceus encoding glycosyltransferases involved in transfer of a disaccharide during biosynthesis of the antitumor drug mithramycin.
Fernández E; Weissbach U; Sánchez Reillo C; Braña AF; Méndez C; Rohr J; Salas JA
J Bacteriol; 1998 Sep; 180(18):4929-37. PubMed ID: 9733697
[TBL] [Abstract][Full Text] [Related]
5. Engineering precursor metabolite pools for increasing production of antitumor mithramycins in Streptomyces argillaceus.
Zabala D; Braña AF; Flórez AB; Salas JA; Méndez C
Metab Eng; 2013 Nov; 20():187-97. PubMed ID: 24148183
[TBL] [Abstract][Full Text] [Related]
6. The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives.
Lombó F; Menéndez N; Salas JA; Méndez C
Appl Microbiol Biotechnol; 2006 Nov; 73(1):1-14. PubMed ID: 17013601
[TBL] [Abstract][Full Text] [Related]
7. Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy.
Albertini V; Jain A; Vignati S; Napoli S; Rinaldi A; Kwee I; Nur-e-Alam M; Bergant J; Bertoni F; Carbone GM; Rohr J; Catapano CV
Nucleic Acids Res; 2006; 34(6):1721-34. PubMed ID: 16571899
[TBL] [Abstract][Full Text] [Related]
8. Ketopremithramycins and ketomithramycins, four new aureolic acid-type compounds obtained upon inactivation of two genes involved in the biosynthesis of the deoxysugar moieties of the antitumor drug mithramycin by Streptomyces argillaceus, reveal novel insights into post-PKS tailoring steps of the mithramycin biosynthetic pathway.
Remsing LL; Garcia-Bernardo J; Gonzalez A; Künzel E; Rix U; Braña AF; Bearden DW; Méndez C; Salas JA; Rohr J
J Am Chem Soc; 2002 Feb; 124(8):1606-14. PubMed ID: 11853433
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target.
Remsing LL; Bahadori HR; Carbone GM; McGuffie EM; Catapano CV; Rohr J
Biochemistry; 2003 Jul; 42(27):8313-24. PubMed ID: 12846580
[TBL] [Abstract][Full Text] [Related]
10. Generation of new derivatives of the antitumor antibiotic mithramycin by altering the glycosylation pattern through combinatorial biosynthesis.
Pérez M; Baig I; Braña AF; Salas JA; Rohr J; Méndez C
Chembiochem; 2008 Sep; 9(14):2295-304. PubMed ID: 18756551
[TBL] [Abstract][Full Text] [Related]
11. Characterization of two glycosyltransferases involved in early glycosylation steps during biosynthesis of the antitumor polyketide mithramycin by Streptomyces argillaceus.
Blanco G; Fernández E; Fernández MJ; Braña AF; Weissbach U; Künzel E; Rohr J; Méndez C; Salas JA
Mol Gen Genet; 2000 Jan; 262(6):991-1000. PubMed ID: 10660060
[TBL] [Abstract][Full Text] [Related]
12. Rationally designed glycosylated premithramycins: hybrid aromatic polyketides using genes from three different biosynthetic pathways.
Trefzer A; Blanco G; Remsing L; Künzel E; Rix U; Lipata F; Braña AF; Méndez C; Rohr J; Bechthold A; Salas JA
J Am Chem Soc; 2002 May; 124(21):6056-62. PubMed ID: 12022840
[TBL] [Abstract][Full Text] [Related]
13. Insertional inactivation of mtrX and mtrY genes from the mithramycin gene cluster affects production and growth of the producer organism Streptomyces argillaceus.
Garcia-Bernardo J; Braña AF; Méndez C; Salas JA
FEMS Microbiol Lett; 2000 May; 186(1):61-5. PubMed ID: 10779713
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Streptomyces argillaceus genes encoding a polyketide synthase involved in the biosynthesis of the antitumor mithramycin.
Lombó F; Blanco G; Fernández E; Méndez C; Salas JA
Gene; 1996 Jun; 172(1):87-91. PubMed ID: 8654997
[TBL] [Abstract][Full Text] [Related]
15. The mtmVUC genes of the mithramycin gene cluster in Streptomyces argillaceus are involved in the biosynthesis of the sugar moieties.
González A; Remsing LL; Lombó F; Fernández MJ; Prado L; Braña AF; Künzel E; Rohr J; Méndez C; Salas JA
Mol Gen Genet; 2001 Feb; 264(6):827-35. PubMed ID: 11254130
[TBL] [Abstract][Full Text] [Related]
16. A novel mithramycin analogue with high antitumor activity and less toxicity generated by combinatorial biosynthesis.
Núñez LE; Nybo SE; González-Sabín J; Pérez M; Menéndez N; Braña AF; Shaaban KA; He M; Morís F; Salas JA; Rohr J; Méndez C
J Med Chem; 2012 Jun; 55(12):5813-25. PubMed ID: 22578073
[TBL] [Abstract][Full Text] [Related]
17. Oxidative cleavage of premithramycin B is one of the last steps in the biosynthesis of the antitumor drug mithramycin.
Prado L; Fernández E; Weissbach U; Blanco G; Quirós LM; Braña AF; Méndez C; Rohr J; Salas JA
Chem Biol; 1999 Jan; 6(1):19-30. PubMed ID: 9889148
[TBL] [Abstract][Full Text] [Related]
18. Analysis of two chromosomal regions adjacent to genes for a type II polyketide synthase involved in the biosynthesis of the antitumor polyketide mithramycin in Streptomyces argillaceus.
Prado L; Lombó F; Braña AF; Méndez C; Rohr J; Salas JA
Mol Gen Genet; 1999 Mar; 261(2):216-25. PubMed ID: 10102355
[TBL] [Abstract][Full Text] [Related]
19. Cloning and insertional inactivation of Streptomyces argillaceus genes involved in the earliest steps of biosynthesis of the sugar moieties of the antitumor polyketide mithramycin.
Lombó F; Siems K; Braña AF; Méndez C; Bindseil K; Salas JA
J Bacteriol; 1997 May; 179(10):3354-7. PubMed ID: 9150235
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer.
Malek A; Núñez LE; Magistri M; Brambilla L; Jovic S; Carbone GM; Morís F; Catapano CV
PLoS One; 2012; 7(4):e35130. PubMed ID: 22545098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
